TARO PHARMS FDA Approval ANDA 215713

ANDA 215713

TARO PHARMS

FDA Drug Application

Application #215713

Application Sponsors

ANDA 215713TARO PHARMS

Marketing Status

Prescription001

Application Products

001CREAM;TOPICAL0.025%0TRETINOINTRETINOIN

FDA Submissions

UNKNOWN; ORIG1AP2023-01-05STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TARO PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215713
            [companyName] => TARO PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRETINOIN","activeIngredients":"TRETINOIN","strength":"0.025%","dosageForm":"CREAM;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/05\/2023","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-05
        )

)

© 2023 FDA.report
This site is not affiliated with or endorsed by the FDA.